Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 412 across all filing types
Latest filing 2023-05-22 Transaction in Own Shar…
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement dated May 22, 2023, titled "NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen" (Publication of Capital Market Information). The key content revolves around the "Erwerb eigener Aktien: 1. Zwischenmeldung" (Acquisition of own shares: 1st Interim Report) under the share buyback program, detailing the number of shares repurchased between May 15 and May 19, 2023, along with daily weighted average prices. This directly relates to the company managing its own stock via repurchase. The category 'Transaction in Own Shares' (POS) is the most specific fit for reporting on share buybacks/repurchases.
2023-05-22 German
NanoRepro AG: Lisa Jungst, buy
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. Section 1 identifies the person (Lisa Jüngst, Member of the managing body), and Section 4 details the transaction (Acquisition of Shares). This directly corresponds to the definition of Director's Dealing, which is classified as 'DIRS'. The document is short and appears to be a direct regulatory disclosure rather than an announcement of a larger report.
2023-05-17 English
NanoRepro AG: Dr. Olaf Stiller, buy
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details the name of a director (Dr. Olaf Stiller), his position, and the nature, price, and volume of a share acquisition transaction. This content directly matches the definition for Director's Dealing (DIRS). The document length is short, but the content is the primary disclosure itself, not an announcement of a separate report.
2023-05-16 English
NanoRepro AG: NanoRepro veroffentlicht Ergebnisse fur das Geschaftsjahr 2022
Earnings Release Classification · 100% confidence The document is titled "NanoRepro AG: NanoRepro veröffentlicht Ergebnisse für das Geschäftsjahr 2022" (NanoRepro AG: NanoRepro publishes results for the fiscal year 2022). It explicitly mentions key financial figures for the year (Umsatz 2022, EBITDA) and states that the company "hat heute den testierten Jahresabschluss 2022 veröffentlicht" (has published the audited annual financial statements for 2022 today). Although it contains detailed financial results, the structure and introductory nature (mentioning the publication of the full report via a link) suggest it is the initial announcement of the annual results, rather than the full 10-K document itself. The key indicators are the focus on annual results and the presence of a link to the full report. This aligns best with the Earnings Release (ER) category, which covers the initial announcement of periodical financial results (in this case, annual results). It is not the full 10-K, nor is it just a short announcement of publication (RPA), as it contains substantial summary data. FY 2022
2023-05-04 German
Jahresabschluss 2022
Audit Report / Information Classification · 98% confidence The document is titled "Jahresabschluss" (Annual Financial Statements) and contains a detailed table of contents listing sections like "Lagebericht" (Management Report), "Jahresabschluss" (Financial Statements including Balance Sheet and Income Statement), and the "Bestätigungsvermerk des unabhängigen Abschlussprüfers" (Auditor's Report). It explicitly covers the fiscal year ending 31.12.2022 and includes a report from the Supervisory Board and details about the management board. This structure is characteristic of a comprehensive annual report, which aligns with the definition of a 10-K (Annual Report), even though the document is in German and likely filed under local regulations (like the German 'Geschäftsbericht'). Given the comprehensive nature and inclusion of the full financial statements and management/supervisory reports, 10-K is the most appropriate classification among the provided options for a full annual filing. FY 2022
2023-05-04 German
Bekanntmachung von Informationen zum Aktienruckkaufprogramm gema Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 in Verbindung mit Artikel 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement dated April 28, 2023, titled "Bekanntmachung von Informationen zum Aktienrückkaufprogramm gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014..." (Announcement of information on the share buyback program...). It details the decision by the Management Board to execute a share repurchase program up to EUR 3 million, specifying the timeframe (May 15, 2023, to April 30, 2024), the maximum number of shares (1,290,377), and compliance with EU regulations (MAR/Delegated Regulation 2016/1052). This content directly relates to the company managing its own capital structure by buying back shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). It is not a general financing update (CAP) but a specific action regarding share repurchase.
2023-04-28 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.